These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 2961218)
1. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation. Zatta A; Zanetti A; Dejana E; Prosdocimi M Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218 [TBL] [Abstract][Full Text] [Related]
2. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro. Prosdocimi M; Zatta A; Gorio A; Zanetti A; Dejana E Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):305-10. PubMed ID: 3012375 [TBL] [Abstract][Full Text] [Related]
3. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H; Stegmeier K Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863 [TBL] [Abstract][Full Text] [Related]
5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
6. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium. Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700 [TBL] [Abstract][Full Text] [Related]
7. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. Fouque F; Vargaftig BB Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269 [TBL] [Abstract][Full Text] [Related]
8. ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations. Bretschneider E; Glusa E; Schrör K Thromb Res; 1994 Aug; 75(3):233-42. PubMed ID: 7992234 [TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium. Packham MA; Kinlough-Rathbone RL; Mustard JF Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698 [TBL] [Abstract][Full Text] [Related]
10. Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation. Krishnamurthi S; Westwick J; Kakkar VV Thromb Haemost; 1982 Oct; 48(2):136-41. PubMed ID: 6891107 [TBL] [Abstract][Full Text] [Related]
11. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. Cattaneo M; Canciani MT; Mannucci PM Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505 [TBL] [Abstract][Full Text] [Related]
13. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid. Brammer JP; Maguire MH Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500 [TBL] [Abstract][Full Text] [Related]
14. [Effects of platelet activating factor on release of thromboxane B2 from human granulocytes and platelets]. Imai T; Horikoshi S; Kurokawa M; Idaira K; Mita S; Adachi M; Okamoto M Arerugi; 1994 Jul; 43(7):809-14. PubMed ID: 7980021 [TBL] [Abstract][Full Text] [Related]
15. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders. Smith IL; Martin TJ Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399 [TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. Rao AK; Willis J; Hassell B; Dangelmaier C; Holmsen H; Smith JB Am J Hematol; 1984 Aug; 17(2):153-65. PubMed ID: 6431801 [TBL] [Abstract][Full Text] [Related]
17. Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro. Marcus AJ; Safier LB; Ullman HL; Wong KT; Broekman MJ; Weksler BB; Kaplan KL Blood; 1981 Nov; 58(5):1027-31. PubMed ID: 6457658 [TBL] [Abstract][Full Text] [Related]
18. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine. Zanetti A; Zatta A; Prosdocimi M; Dejana E Eur J Pharmacol; 1986 Aug; 128(1-2):119-27. PubMed ID: 2944757 [TBL] [Abstract][Full Text] [Related]
19. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes. Korth R; Riess H; Brehm G; Hiller E Thromb Res; 1986 Mar; 41(5):699-706. PubMed ID: 3961742 [TBL] [Abstract][Full Text] [Related]
20. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium. Yi FX; Guo ZG Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]